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Abstract
Background: Melatonin has immunomodulatory effects but very little is known about its influence in protozoan
infections, such as Entamoeba histolytica, which causes amoebiasis, a disease with significant morbidity and
mortality. In this study, we evaluated the effects of exogenous melatonin interference in experimental amoebiasis
and on interactions between human blood cells and E. histolytica trophozoites.
Methods: The effect of melatonin was investigated in models of experimental amoebiasis in hamsters and rats by
evaluating the area of necrosis induced by E. histolytica. The activity of melatonin on the interactions between
leukocytes and amoebae was determined by examining leukophagocytosis. For in vitro tests, polymorphonuclear
and mononuclear human blood leucocytes were incubated with E. histolytica trophozoites.
Results: The areas of amoebic necrosis were significantly reduced in animals treated with melatonin. Melatonin
treatment increased leukophagocytosis but was associated with a greater number of dead amoebae.
Conclusions: These results suggest that melatonin may play a beneficial role in the control of amoebic lesions,
raising the possibility that this drug may be used as an adjuvant in anti-amoebic therapy.
Background
Melatonin [N-acetyl-5-methoxytryptamine] is an indo-
leamine synthesised from tryptophan. The physiological
properties of melatonin are not limited to its neuroen-
docrine role in controlling circadian rhythms [1]; several
other actions have been discovered. Melatonin has been
shown to increase innate and acquired immunity [2], to
activate the bone marrow and lymph nodes [3], to
enhance NK cell activity [4,5] and antibody-dependent
cell cytotoxicity [6], to increase T cell proliferation in
vivo and in vitro [7,8] and to activate monocytes [9,10]
and neutrophils [11].
Melatonin can stimulate innate immune cells, primarily
leukocytes, which represents an important anti-bacterial
mechanism [12,13]; however, very little is known about
its influence on protozoan infections.
Entamoeba histolytica is an enteric protozoan parasite
that infects 500 million people, causes amoebiasis in 50
million and kills 100 000 individuals annually, thus
constituting a serious health public problem [14]. The
disease is widely distributed worldwide, but its incidence
is highest in places with insufficient basic sanitation.
Several aspects of this host parasite relationship, such as
parasite virulence and host susceptibility, are poorly
understood. The course of infection begins with an
inflammatory process that recruits eosinophils, lympho-
cytes, neutrophils and macrophages [15]; however,
despite this immune cell recruitment, tissue destruction
progresses, generating a typical amoebic necrotic area.
Melatonin has been reported to have immunomodula-
tory effects in the cases of toxoplasmosis [16-18],
malaria [19,20] and Chagas disease [21].
One of these studies investigated the effect of melato-
nin and zinc on the immune response to Toxoplasma
gondii retinochoroiditis in the rat model (pinealectomy
or not) of infection and to establish the possible value
of supplementation as adjunctive therapeutic agents in
the treatment of T. gondii retinochoroiditis. Melatonin
should be considered as an adjunctive therapy to classic
treatment of Toxoplasma retinochoroiditis, especially in
immunosuppressed and elderly patients if our data are
confirmed in a clinical setting [18].
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nin showed a significant reduction in the number of
blood trypomastigotes during the acute phase of infec-
tion compared with untreated animals and increase in
leucocytes numbers during the peak of parasitaemia
[21].
Nothing has yet been reported regarding amoebiasis.
This pioneering study aims to evaluate the influence of
exogenous melatonin in experimental amoebic infections




E. histolytica-infected hamsters that were treated with
melatonin exhibited significantly reduced areas of hepa-
tic necrosis relative to those in the control group (p <
0.05). The necrotic areas in the melatonin-treated ani-
mals were about half the size of the lesions in the
untreated animals (Figure 1). Furthermore, only 1 of the
6 rats treated with melatonin showed amoebic lesions in
its caecum, whereas 5 of the 6 untreated rats had caecal
lesions.
Figure 2 shows the histopathological analysis of ham-
sters inoculated with the HM1 strain of E. histolytica
either without (a and b) or with melatonin treatment (c
and d). The area of tissue destruction was smaller in
animals that were treated with melatonin than in con-
trols that did not receive melatonin treatment. Micro-
scopic observation of hepatic tissues from animals that
did not receive treatment showed that necrosis was
often distributed over wide areas. In contrast, necrotic
regions were interspersed between areas of normal tis-
sue in animals that received melatonin treatment. The
inflammatory infiltrate was more intense in the treated
animals and showed focal zones comprised of large
numbers of mononuclear cells and some giant cells.
These focal zones were absent in animals that did not
receive melatonin treatment.
In vitro results
Melatonin increased the adherence of E. histolytica tro-
phozoites to mononuclear (MN) and polymorphonuclear
(PMN) leukocytes.” The highest adherence rate (80.4%)
was seen with MN cells in the presence of melatonin. In
analysing the ingestion of leukocytes by the amoebae,
we found that melatonin only induced a significant
increase in the ingestion of PMN leukocytes: the inges-
tion rate was 50.6% in the absence of melatonin and
62% in its presence. We observed a significant increase
in the percentage of dead amoebae during leukocyte
internalization in the presence of melatonin, with the
frequency of dead amoebae increasing by 26% for those
ingesting MN leucocytes and 24% for those ingesting
PMN leucocytes, relative to those in non-melatonin-
treated cultures (Figures. 3a and 3b).
During phagocytosis, in the presence of melatonin,
superoxide released from MN interacting with amoebae
was 26.2 nmol and PMN interacting with amoebae was
27.8 nmol. The controls were 10.4 nmol and 16.6 nmol
respectively. SOD released from MN interacting with
amoebae was 108.8 and PMN interacting with amoebae
was 125.6. The controls in the absence of melatonin
were 76.4 and 66.6 respectively.
Figure 1 Amoebic hepatic necrosis. Amoebic hepatic necrosis
in mm
2 and standard deviation in hamsters treated and not treated
with melatonin.
Figure 2 Histology of liver from hamsters. Histology of liver from
hamsters inoculated with the HM1 strain of E. histolytica. (a)
significant necrosis of the liver parenchyma (N) of untreated
hamster melatonin. Non-necrotic hepatic parenchyma (H), (b) Detail
of preceding figure showing trophozoites (arrowheads) adjacent to
the large amount of cellular debris and moderate inflammatory
infiltrate (*). Necrosis (N), (c) non-necrotic hepatic parenchyma (H) of
hamsters that received melatonin. Note the presence of focal
inflammatory infiltrate rich in mononuclear cells (arrows).
Granulation tissue (*). Portal space (P), (d) Detail of previous picture
showing one of the focal infiltrates predominantly composed of
lymphocytes and macrophages. Non-necrotic liver parenchyma (H).
H&E. (a) and (c) Bar 100 μm; (b) and (d) Bar 20 μm.
França-Botelho et al. Parasites & Vectors 2011, 4:62
http://www.parasitesandvectors.com/content/4/1/62
Page 2 of 6Discussion
Little is known about the immunomodulatory effects of
melatonin in protozoan infections. This study is the first
to evaluate the action of melatonin on E. histolytica in
vivo and in vitro. The results of our experimental amoe-
biasis studies showed a significant reduction in the areas
of amoebic necrosis in response to melatonin treatment.
In the treated animals, areas of necrosis were often asso-
ciated with large amounts of predominantly mononuclear
inflammatory infiltrate, which suggests that melatonin
likely induces Th1 immune responses, thereby containing
the infection and reducing the size of liver abscesses.
Amoebae-derived substances are known to be important
factors for tissue damage [22-24]. Therefore, the reduction
of necrotic areas may also be related to parasite factors,
such as proteinases and amoebapores, which may be present
in smaller proportions in the areas treated with melatonin,
given the reduced presence of trophozoites in these regions.
It is worth mentioning that hamsters were chosen as
an experimental infection model because they are more
susceptible to infection by E. histolytica than mice, and
criteria for determining the severity of their injuries are
well established, thus allowing differences resulting from
the administration of melatonin to be better distin-
guished. Our results indicate that there are beneficial
effects of exogenous melatonin, corroborating reports
that have evaluated melatonin as a modulator of other
parasitic infections [16-21,25].
In a model of schistosomiasis in hamsters, melatonin
increases the efficacy of cercarial and soluble worm anti-
gens in inducing protective immunity against infection,
suggesting possible applications in a vaccination program
[26]. Melatonin can synchronize the cycle of the malaria
parasite; the rupture of infected erythrocytes coincides
with the timed release of melatonin in vertebrates, which
occurs between midnight and three a.m. [27].
Phagocytosis plays an important role in E. histolytica
pathogenicity, making it an object of investigations.
A comprehensive evaluation of the phagocytic capacity
of amoebae involves leukophagocytosis because amoebae
are constantly in contact with leukocytes in vivo and
must be able to destroy them to survive.
The identification of substances involved in leukocyte
activation during amoeba-leukocyte interactions would
help to direct the appropriate therapeutic use of these
substances in amoebiasis. In this context, we evaluated
the action of melatonin, a known immunomodulator,
during PMN and MN leukophagocytosis performed by
E. histolytica trophozoites.
Classical studies involving amoebae and leukocytes
[28,29] have shown that virulent strains of amoebae are
lethal for leukocytes, which lose their motility and are
then phagocytosed and killed by the amoebae. In this
study, we observed an increase in the rate of leukophago-
cytosis in the presence of the melatonin; however, this was
accompanied by significantly higher rates of dead amoebae
during the process. This suggests that melatonin plays a
beneficial role for the host by activating PMN and MN
cells. In addition, higher levels of superoxide anion and
superoxide dismutase (SOD) were obtained during inter-
actions in the presence of melatonin, which correlates
with higher microbicidal leukocyte activity. Increased SOD
may reflect antioxidant properties of melatonin which may
be related to the reduced tissue damage.
These results suggest the need for further studies aim-
ing to elucidate the mechanism of melatonin action
in the host immune response. It would also be interest-
ing to evaluate whether associations with other drugs
may enhance the beneficial effects of melatonin in
amoebiasis, as has been demonstrated for infections
with Trypanosoma cruzi [30].
Conclusions
The reduction in the areas of necrosis observed in
experimental amoebic infection of hamsters and rats,

Figure 3 Leukophagocytosis.E f f e c t so fm e l a t o n i no n
leukophagocytosis of mononuclear (A) and polymorphonuclear (B)
human leukocytes accomplished by amoebae, evaluated by the
parameters: adherence, leukocytes ingestion, killing leukocytes and
killing amoebae. Results are the percent means and standard
deviation of 5 repetitions. Statistically different (p < 0.05) versus
control (melatonin absent).
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leukophagocytosis, suggests that melatonin may play a
beneficial role in the control of amoebic lesions and
indicates that, as in other diseases, melatonin may be
useful as an adjuvant in anti-amoebic therapy.
Methods
All procedures were evaluated and institutionally
approved by the Ethics Committee (protocol 6815/41),
in compliance with the Helsinki Declaration and inter-
national guidelines for experimental research on
animals.
In vivo experiments
Trophozoites of the virulent strain of E. histolytica
HM1:IMSS were grown axenically in a TYI-S-33 med-
ium [31]. Parasites were maintained with thrice-weekly
sub-cultures, assuring their use in the exponential
growth phase.
Amoebas from axenic cultures were centrifuged at 200
× g in individual tubes, washed twice with PBS (pH 7.2)
and adjusted to 1 × 10
6 amoebae in 0.1 mL of inoculum.
Six hamsters (Mesocricetus auratus), intestinal amoebia-
sis model and and six Wistar rats (Rattus norvegicus)
amoebic liver model [32] were used for each group of
experiments. In the case of both species the animals were
male and approximately 40 days old, with the hamsters
weighing around 60 g and the rats weighing around 110 g.
The animals were anesthetized with sodium pentobarbi-
tal (30 mg/kg for rats and 79 mg/kg for hamsters) and
laparotomised, and the amoebae were inoculated directly
into the liver (hamsters) or caecum (Wistar rats). Six days
after inoculation, animals were sacrificed and dissected for
macroscopic examination of the liver or caecum. Frag-
ments of hamster livers and rat caeca were fixed in 10%
buffered formalin, pH 7.2. After the fixation period, the
fragments were dehydrated, diaphanised,[what is diapha-
nised? Do you mean cleared?] infiltrated and embedded in
paraffin. Sections obtained for staining with hematoxylin
and eosin (H&E) were 4 mm [not mm surely??] thick.
Areas of amoebic liver necrosis were quantified using
the KS300 software contained in the Carl Zeiss image
analyser. For the evaluation of necrosis, the sections
were examined “in totum” and all images of destroyed
liver parenchyma were digitalised using a 4× or 10×
objective lens and a JVC TK-1270/RGB micro camera.
The caeca were examined under an optical microscope
to assess the presence or absence of amoebic lesions.
The inoculated animals were treated with melatonin
(Sigma, St. Louis, MO, USA) subcutaneously [33] at a
dose of 15 mg/kg body weight [34]. The drug was dis-
solved in deionised water and given once a day during
the six days of the experiment. Treatment was started
on the same day as the infection. All procedures for
handling melatonin occurred in a darkened room.
In vitro experiments
After obtaining written consent, heparinised blood was
obtained from 5 healthy male volunteers aged 18-36
years old. Each sample comprised of approximately 10
ml of blood. A total of 15 samples (3 samples from each
donor) were collected in order to complete the different
experiments.
The heparinised blood was fractioned by centrifuga-
tion with Ficoll-Paque (Pharmacia, Upsala, Sweden) and
subjected to sedimentation with dextran. This separation
resulted in the formation of a PMN leukocyte sediment
and an MN leucocyte layer at the Ficoll-Paque interface.
This procedure resulted in preparations of 95% pure
MN and PMN cells. MN and PMN cells were resus-
pended in PBS (phosphate buffered saline - pH 7.4)a n d
washed. Resulting suspensions were adjusted to a con-
centration of 2 × 10
6 cells/mL [35].
One millilitre suspensions comprising leukocytes (2
× 106/mL) and amoebae (1 × 106/mL) in PBS were
placed in 15 mL Falcon tubes. The tubes were briefly
filled to 95% of their capacity with PBS and each sus-
pension of leucocytes (either MN or PMN) and amoe-
bae was then pelleted and resuspended in 1 mL of
PBS. The tubes were then shaken at 37°C for 60 min-
utes to allow the leucocytes to interact with the tro-
phozoites. Assays with the MN and PMN cells were
adapted from a previously published protocol [35]. To
evaluate possible melatonin effects on amoebae and
leukocytes, the drug was added to the incubation med-
ium at a concentration of 100 ng/mL. This is consid-
ered to be a pharmacological dose [36] and is generally
used to evaluate cellular activation [37].
Phagocytosis was interrupted by incubating the tubes
on ice for 10 min. The leukocytes and trophozoites were
then stained with 200 μlo fa c r i d i n eo r a n g e( 1 4 . 4m g / L )
for two minutes and washed twice in ice-cold PBS [38].
Indices of adherence, ingestion and death of the tropho-
zoites and leukocytes were determined by fluorescence
microscopy (TIM-4000, Germany) and compared with
controls performed under the same conditions without
the addition of melatonin. One hundred amoebae were
counted per slide.
Superoxide release (O2
-) was measured by reducing
cytochrome C (Sigma) as previously described [39] and
in order to determine the concentration of the enzyme
superoxide dismutase (SOD), the adapted protocol [40].
An unpaired t test was used to analyse differences in
leukophagocytosis between the two groups. Differences
were considered to be statistically significant when the p
value was lower than 0.05.
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